Literature DB >> 1573636

Syntheses, resolution, and structure-activity relationships of potent acetylcholinesterase inhibitors: 8-carbaphysostigmine analogues.

Y L Chen1, J Nielsen, K Hedberg, A Dunaiskis, S Jones, L Russo, J Johnson, J Ives, D Liston.   

Abstract

The synthesis of a series of 1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrole 5-alkylcarbamates and their resolution are reported. These compounds are structurally related to physostigmine with substitution of a methylene group in place of the NMe group at position 8 of physostigmine. Many of these 8-carbaphysostigmine analogues are more potent acetylcholinesterase inhibitors in vitro and less toxic in vivo than physostigmine. The (-)-enantiomer (e.g., 1d and 1g) possessing the same absolute configuration at C3a and C8a as that of physostigmine, is about 6 to 12-fold more potent at inhibiting acetylcholinesterase than the corresponding (+)-enantiomer (e.g., 1e and 1h).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1573636     DOI: 10.1021/jm00086a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.

Authors:  N Ariel; A Ordentlich; D Barak; T Bino; B Velan; A Shafferman
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

2.  Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions.

Authors:  Dov Barak; Arie Ordentlich; Dana Stein; Qian-Sheng Yu; Nigel H Greig; Avigdor Shafferman
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

3.  Pharmacophore-based design and discovery of (-)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis.

Authors:  Qiong Xie; Zhaoxi Zheng; Biyun Shao; Wei Fu; Zheng Xia; Wei Li; Jian Sun; Wei Zheng; Weiwei Zhang; Wei Sheng; Qihong Zhang; Hongzhuan Chen; Hao Wang; Zhuibai Qiu
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.